| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113762.1.4.1235.228 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.228 |
| version | 20230118 |
| status | active |
| publisher | B.well Connected Health Steward |
| name | InfluenzaVaccineCN_HD_SNOMED |
| title | Influenza Vaccine CN_HD_SNOMED |
| date | 2023-01-18T01:03:05-05:00 |
| description | b.well created value set by Sr. Clinical Business Analyst for Influenza Vaccine - Adult Care Need. |
| Usages |
|
This value set contains 24 concepts
| Code | System | Display |
| 127787002 | http://snomed.info/sct | Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 16292241000119109 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure) |
| 170343007 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170344001 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170345000 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170346004 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 310306005 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 310307001 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 310308006 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 312869001 | http://snomed.info/sct | Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 312870000 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 414001002 | http://snomed.info/sct | Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 414259000 | http://snomed.info/sct | Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 415507003 | http://snomed.info/sct | Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 415712004 | http://snomed.info/sct | Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 770608009 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770616000 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770617009 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770618004 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 786846001 | http://snomed.info/sct | Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 786847005 | http://snomed.info/sct | Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure) |
| 787016008 | http://snomed.info/sct | Administration of vaccine product containing only Influenza virus antigen in nasal dose form (procedure) |
| 787436003 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure) |
| 86198006 | http://snomed.info/sct | Administration of vaccine product containing only Influenza virus antigen (procedure) |
Produced 08 Sep 2023